Can a Biohybrid Patch Salvage Ventricular Function at a Late Time Point in the Post-Infarction Remodeling Process?

Area of Science:

• Biomaterials science
• Cardiovascular research
• Regenerative medicine

Background:

• Large myocardial infarctions lead to heart dilation and impaired function.
• Current treatments for advanced heart failure have limitations.
• Cell-free therapeutic strategies are emerging for cardiac repair.

Purpose of the Study:

• To evaluate the efficacy of a cell-free biohybrid patch in treating large infarcted areas in dilated hearts.
• To assess the impact of the patch on cardiac morphology and function.
• To determine if the patch benefits particularly frail patients with low ejection fraction.

Main Methods:

• A biohybrid patch was implanted over infarcted regions in an animal model.
• Control groups received no patch or losartan therapy.
• Echocardiography was used to assess cardiac function and morphology.

Main Results:

• Patch implantation led to improved echocardiographic endpoints compared to control groups.
• Benefits were more pronounced in animals with pre-treatment ejection fraction below 35%.
• Patched hearts exhibited smaller infarct sizes than nonpatched hearts.

Conclusions:

• A cell-free biohybrid patch can improve ventricular remodeling and function after myocardial infarction.
• This approach may offer a promising, minimally invasive therapeutic option for heart failure patients, especially the frail.
• Further clinical translation of this biohybrid patch technology is warranted.